Semaglutide**
Industrial Grade
99.99%
shenzhen
5mg*10vials 10mg*10vials 15mg*10vials 20mg*10vials 30mg*10vials 40mg*10vials 50mg*10vials 60mg*10vials 100mg*10vials
2026-11-18
Tirzepatide,Retatrutide,Semaglutide
-
Product Details
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
fit
Categories:
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide
-
Location:
Unit 1207, Elevator 1, Office Tower A2, Wanda Plaza, No. 8 Aojiang Road, Taijiang District, Fuzhou City, Fujian Province
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
1 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2024
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Vitamin B12 Additives Pharmaceutical Grade Raw Powder
Pharmaceutical Grade / 99.999%
-
-
-
-
MIC(lipo C with B12) 10mg
Pharmaceutical Grade / 99%
$75-80/UNIT FOB
-
-
-
-
Cortagen 20mg
Pharmaceutical Grade / 99%
$80-85/UNIT FOB
-
-
-
-
Selank 99% 5mg 10mg
Pharmaceutical Grade / 99%
$40-45/UNIT FOB
-
-
-
-
Adipotide11 Factory direct delivery Best value for money Powder 99% purity
Pharmaceutical Grade / 99.999%
-
-
-
-
CAS 1627580-64-6 Most-C Wholesale Peptide with Fast Global Shipping and Custom Packaging_
Pharmaceutical Grade / 99.99%
$9-10/G FOB
-